Using Nerivio® for Migraine Prevention Results in Significant Clinical and Cost-Saving Benefits for Patients, Insurers, and Employers, According to a New Health Economics Study

Nerivio Can Greatly Reduce Payer Expenses Through Reduction of Migraine Headache Days, Productivity Loss, and Healthcare Utilization Costs NETANYA, Israel and BRIDGEWATER, N.J., May 16, 2023 /PRNewswire/ — Theranica, a prescribed digital therapeutics company developing advanced neuromodulation devices for migraine and other pain conditions, announced the results of a recent study published in the Journal … Read more